The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat

M. A. Moron, Craig Stevens, T. L. Yaksh

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

By using a rat seizure model, a comparison of the antiseizure activity of 12 dihydropyridine calcium channel antagonists (administered i.c.v.) to their binding affinities for the neuronal site known to regulate L-type calcium channels was made. For these dihydropyridine calcium channel antagonists a correlation between physiologic activity and binding affinities would provide evidence that these agents exert their antiseizure actions via a mechanism involving a binding site that regulates L-type neuronal calcium channels. Despite i.c.v. administration, a parallel in antiseizure activity and binding affinities could not be demonstrated precisely, suggesting that the dihydropyridines may be exerting their antiseizure activity by more than just simple neuronal calcium channel blockade.

Original languageEnglish
Pages (from-to)1150-1155
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume252
Issue number3
StatePublished - 27 Apr 1990

Fingerprint

L-Type Calcium Channels
Calcium Channel Blockers
Dihydropyridines
Calcium Channels
Seizures
Binding Sites
1,4-dihydropyridine

Cite this

@article{b376b70741f24fbabfe9537b09ac5a6e,
title = "The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat",
abstract = "By using a rat seizure model, a comparison of the antiseizure activity of 12 dihydropyridine calcium channel antagonists (administered i.c.v.) to their binding affinities for the neuronal site known to regulate L-type calcium channels was made. For these dihydropyridine calcium channel antagonists a correlation between physiologic activity and binding affinities would provide evidence that these agents exert their antiseizure actions via a mechanism involving a binding site that regulates L-type neuronal calcium channels. Despite i.c.v. administration, a parallel in antiseizure activity and binding affinities could not be demonstrated precisely, suggesting that the dihydropyridines may be exerting their antiseizure activity by more than just simple neuronal calcium channel blockade.",
author = "Moron, {M. A.} and Craig Stevens and Yaksh, {T. L.}",
year = "1990",
month = "4",
day = "27",
language = "English",
volume = "252",
pages = "1150--1155",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat. / Moron, M. A.; Stevens, Craig; Yaksh, T. L.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 252, No. 3, 27.04.1990, p. 1150-1155.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat

AU - Moron, M. A.

AU - Stevens, Craig

AU - Yaksh, T. L.

PY - 1990/4/27

Y1 - 1990/4/27

N2 - By using a rat seizure model, a comparison of the antiseizure activity of 12 dihydropyridine calcium channel antagonists (administered i.c.v.) to their binding affinities for the neuronal site known to regulate L-type calcium channels was made. For these dihydropyridine calcium channel antagonists a correlation between physiologic activity and binding affinities would provide evidence that these agents exert their antiseizure actions via a mechanism involving a binding site that regulates L-type neuronal calcium channels. Despite i.c.v. administration, a parallel in antiseizure activity and binding affinities could not be demonstrated precisely, suggesting that the dihydropyridines may be exerting their antiseizure activity by more than just simple neuronal calcium channel blockade.

AB - By using a rat seizure model, a comparison of the antiseizure activity of 12 dihydropyridine calcium channel antagonists (administered i.c.v.) to their binding affinities for the neuronal site known to regulate L-type calcium channels was made. For these dihydropyridine calcium channel antagonists a correlation between physiologic activity and binding affinities would provide evidence that these agents exert their antiseizure actions via a mechanism involving a binding site that regulates L-type neuronal calcium channels. Despite i.c.v. administration, a parallel in antiseizure activity and binding affinities could not be demonstrated precisely, suggesting that the dihydropyridines may be exerting their antiseizure activity by more than just simple neuronal calcium channel blockade.

UR - http://www.scopus.com/inward/record.url?scp=0025215471&partnerID=8YFLogxK

M3 - Article

C2 - 2319465

AN - SCOPUS:0025215471

VL - 252

SP - 1150

EP - 1155

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -